Singula Bio Analysis: $3M Raised
What is Singula Bio?
Neoantigen-based cell therapies for cancer treatment
Location
Oxford, United Kingdom
Employees
1-10
Founded
2020
Product Features & Capabilities
- Neoantigen-based cell therapies
- Immunological technologies
- Medical technologies
- Surgical technologies
- Computational technologies
Use Cases
Develop individualized cell therapies for ovarian cancer; Create therapies to prevent cancer recurrence; Utilize patient’s immune system to fight cancer; Address solid tumors with selective therapies; Innovate cancer treatment methods
Other Considerations
Founded by experts in cancer medicine and immunology; Team includes experienced professionals in live-cell therapy; Enzo Cerundolo's legacy drives the mission forward
See something that needs updating? Suggest edits to this profile.